PBMC-Based Assays
Sanguine BioSciences & SBH Sciences Announce Collaboration on PBMC-Based Assays
SANTA MONICA, Oct 22, 2010 - Sanguine BioSciences (www.sanguinebio.com) and SBH Sciences (www.sbhsciences.com) today announced that they will begin a collaboration on PBMC-based assays, in which Sanguine will support the ongoing development of SBH’s cell-based assay pipeline by supplying highly viable Peripheral Blood Mononuclear Cells and isolated subpopulations (e.g. CD4+ T cells, CD34+ Stem Cells, etc.).
Under the terms of the agreement, Sanguine will manufacture and supply SBH with
PBMC, Mesenchymal Stem cells, Hematoprogenitor (CD34+) Stem cells, CD4+ T cells,
CD8+ T cells, CD14+ Monocytes, CD19+ B cells, CD56+ NK cells, Basophils,
Neutrophils, Eosinophils, and Dendritic Cells, for the development of the following
assays: Endotoxin-stimulated human PBMC assay, Integrin and Endothelial cell
adhesion assay, T and B cell proliferation assay and Cytokine release assay.
“We are delighted to enter into this agreement”, said Brian Neman, CEO of Sanguine BioSciences. “To work with one of the nation’s leading assay developers on their service pipeline is a great recognition of our efforts to adopt a collaborative approach with our customers. It allows joint manufacturing asset planning to ensure our customers can develop their pipeline of services effectively. We see this as a relationship that will bring significant benefits to both parties.”
About Sanguine BioSciences
Sanguine BioSciences provides highly viable primary human cells and tissues to the academic and industrial life science research community. The product offering spans customers’ needs mainly in the In Vitro Research & Development stage of Drug Development. The organization hold proprietary cryopreservation technology that allows for >90% post-thaw viability of primary human cells and tissues. Sanguine’s vision is to develop into the global leader in high quality cells and tissues for life science research and development.
Sanguine is based in Santa Monica, California, and is a portfolio company of Los Angeles Syndicate of Technology www.last.vc, a venture capital fund that specializes in early-stage internet-technology and biotechnology companies. Further information can be found at www.sanguinebio.com
About SBH Sciences
SBH Sciences provides cell culture based services to the Biotechnology and Pharmaceutical industry and academic researchers. In its twelve year of operation, SBH Sciences is making significant advances in proprietary cell culture technology, specifically in mammalian and insect cell culture, optimizing in-vitro diagnostic methods, as well as customizing the production and purification of recombinant and natural proteins.
SBH Sciences excels in the development and validation of cell-based bioassays for biologically active cytokines and currently has the most comprehensive assay library worldwide. Assays consist of over 250 different cytokines, cytokine receptors and anti-cytokines.
SBH Sciences specializes in cytokine and protein profiling as well as immunological based assays.
###
Please contact us so we can discuss your needs, and ways in which SBH Sciences might be able to work with you. We will be happy to assist
you.
Our expertise is your competitive edge!
|